Lite Strategy, Inc. last reported quarterly results on Jul 30, 2026, for Q4 FY2026 (the quarter ended Jun 30, 2026): diluted EPS of -$0.38. It usually reports 30–48 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 12, 2026.
Results for Q1 FY2027, the quarter ending around Sep 30, 2026. Expected on a Thursday. Based on how many days after a quarter ends the company has reported recently. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 30–48 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Jul 30, 2026
30 days after quarter end
|
Q4 FY2026
ended Jun 30, 2026
|
—
|
-13
-384.3%
|
-0.38
+6.7%
|
|
May 13, 2026
43 days after quarter end
|
Q3 FY2026
ended Mar 31, 2026
|
—
|
-24
-820.9%
|
-0.66
-69.2%
|
|
Feb 17, 2026
48 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
—
|
—
|
—
|
|
May 13, 2025
43 days after quarter end
|
Q3 FY2025
ended Mar 31, 2025
|
0
|
-3
+71.8%
|
-0.39
+71.5%
|
|
Feb 12, 2025
43 days after quarter end
|
Q2 FY2025
ended Dec 31, 2024
|
0
|
-3
+75.8%
|
-0.40
+75.9%
|
|
Nov 14, 2024
45 days after quarter end
|
—
ended Sep 30, 2024
|
—
|
—
|
—
|
|
May 9, 2024
39 days after quarter end
|
—
ended Mar 31, 2024
|
—
|
—
|
—
|
|
Feb 13, 2024
44 days after quarter end
|
—
ended Dec 31, 2023
|
—
|
—
|
—
|
Company profile
- Industry
- Finance Services (SIC 6199)
- Listed as
- LITS (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1262104
- Former names
- MEI Pharma, Inc. (until Sep 10, 2025); MARSHALL EDWARDS INC (until Jun 6, 2012)
Other Finance Services companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.